chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a 75 year old female patient with drug reaction to CELEBREX who on 16-MAR-2009 was vaccinated with single dose of series of ZOSTAVAX (Merck).  On 25-MAR-2009 the patient noticed at the injection site on her left arm there was a red mark and a "big goose egg".  The patient had not sought medical attention.  At the time of reporting the patient's red mark and "big goose egg" at the injection site on her left arm persisted.  No further information is available.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Conjunctivitis infective
Clinical narrative: Information has been received from a 66 year old female patient with "allergy to sulfa drugs" who on 24-MAR-2009 was vaccinated with "one dose" of ZOSTAVAX (Merck) (lot number not available). Concomitant therapy included propranolol HCl, ezetimibe, simvastatin (manufacturer unknown) and aspirin. On 24-MAR-2009 "6 hours after receiving ZOSTAVAX (Merck)" the patient developed "pink eye". The patient had not sought medical attention. At the time of reporting the patient's "pink eye" persisted. No further information is available.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Information has been received from a physician concerning a 74 year old female patient who "1 week ago" on approximately 18-MAR-2009 was vaccinated with ZOSTAVAX (Merck) subcutaneously. Subsequently the patient experienced an exacerbation of chronic obstructive pulmonary disease (COPD) after receiving ZOSTAVAX (Merck). The patient had sought unspecified medical attention via a phone call. No lab tests were performed. At the time of reporting the patient's exacerbation of chronic obstructive pulmonary disease (COPD) persisted. Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Skin lesion
Clinical narrative: Information has been received from a 77 year old male patient with no pertinent medical history or drug reaction or allergies who in May 2008, was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included TOPROL XL TABLETS, AVAPRO, LANOXIN and COUMADIN. In approximately February 2009, "about a month ago", the patient came down with shingles. He had lesions on his right shoulder and some breaking out on his right side of his neck. There was some pain on top of his head down to his neck, shoulder and going under his armpit. The patient was not severe. He was prescribed some antiviral medication and pain medication (unspecified which ones). The patient stated that he was almost fully recovered from the shingles. No lab tests were done. Unspecified medical attention was sought. Additional information has been requested.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Hypertension
Clinical narrative: Information has been received from a 75 year old female consumer with hypertension, who was also the patient, who on 05-MAR-2009 was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included unspecified blood pressure medication (also reported as no concomitant medication). On approximately 12-MAR-2009, "about 1 week after vaccination", the patient experienced a rise in blood pressure. The patient had seen her doctor and her blood pressure medication had been increased. Her blood pressure was as high as 190/99. At the time of this report, the patient's symptoms persisted. The consumer also reported that her husband experienced a rise in blood pressure after vaccinated with ZOSTAVAX (Merck) (WAES # 0903USA05479). Additional information has been requested.
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Herpes zoster, Pyrexia
Clinical narrative: Information has been received from an 83 year old female who in approximately 2008 was vaccinated with ZOSTAVAX vaccine (Merck). Concomitant therapy included COREG. On 15-MAR-2009 the patient experienced fever and headache. On 18-MAR-2009 "the patient started breaking out on her neck and 2 days later she was breaking out on her scalp". The patient's doctor diagnosed this as shingles, additionally the patient stated that her doctor had prescribed LORTAB for the headache "but it made the headache worse". The patient was recovering and she sought unspecified medical attention. Follow up has been received from a physician who reported that the patient (age reported as 70 years old) who was vaccinated with ZOSTAVAX vaccine (Merck) with in the last year and developed shingles. The physician reported, the patient still had an active case of shingles. Additional information has been requested.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache
Clinical narrative: Information has been received from a pharmacist concerning a 78 year old female with no drug reactions or allergies who on 04-Mar-2009 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot # 654801/ 0129U). On 04-Mar-2009 the patient developed a "low grade" headache above her eyes. At the time of this report, the patient's symptoms persisted. The patient spoke to the pharmacist and sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Adverse reaction, Malaise
Clinical narrative: Information has been received from a nurse practitioner (N.P.) concerning a female who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). Subsequently, "after receiving the vaccination", the patient had a "bad" reaction and made her "sick". At the time of this report, the outcome was unknown. The patient was seen by the N.P. and sought unspecified medical attention. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Herpes zoster ophthalmic
Clinical narrative: Information has been received from a physician concerning a 66 year old male who in June 2007, was vaccinated with the first 0.65 ml dose of ZOSTAVAX (Merck). In February 2009, the patient broke out with really bad case shingles. The physician reported that the shingles was from the neck up and there was ophthalmic involvement. At the time of this report, the outcome was unknown. The patient was seen by the physician and sought unspecified medical attention. No further information is available.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site haematoma, Injection site reaction
Clinical narrative: Information has been received from a physician concerning a 61 year old female with hypertension and hyperlipidaemia and no drug reactions or allergies who on 26-MAR-2009 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck) for "diabetic". The physician did not know which arm the ZOSTAVAX (Merck) was given. There were a "few" unspecified concomitant medications. On 27-MAR-2009 the patient experienced injection site reactions such as redness and hematoma and it was getting worse. No lab tests were done. At the time of this report, the patient's symptoms persisted. Unspecified medical attention was sought via phone call. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash erythematous, Rash pruritic
Clinical narrative: Information has been received from a 65 year old female with high blood pressure and allergic to sulfa who 0n 11-MAR-2009 was vaccinated with a dose of ZOSTAVAX vaccine (Merck). Concomitant therapy included lisinopril (manufacture unknown) and NIASPAN. On 20-MAR-2009, 9 days after receiving ZOSTAVAX vaccine (Merck), the patient developed the shingles on her left breast and then it moved to the thoracic area of her upper back. She reported that she saw her physician on a week later and was diagnosed with shingles. Her shingles was improving that the rashes were not as red and not as itchy. Follow up information was received from representative who stated that the patient was fine now. No additional information was provided. Follow up information was received via medical records from the patient's physician which reported the 65 year old patient also had allergic rhinitis due to pollen, essential hypertension, hypercholesterolaemia, asthma NOS and history of osteopenia, hyperlipidaemia, stress urinary incontinence, urge urinary incontinence, depression, seasonal allergy, granuloma annulase extensive rx with puva Ferrell-Blickenstaff-Burr, laryngospasm since at least 1970's triggered by sweets sometimes, father also had them. She underwent breast reduction, liposuction (neck lift), sinus operation, hysterectomy/BSO due to HPV. The patient had a colonoscopy in November 2003 which was negative. Her density in January 2009 was Hip-1.2, Spine-1.5 that indicated osteopenia. The patient quit smoking in 1960, prior 1/2 ppd 1 yr, ,1 ppv and has 4 drinks/week or so. She was subcutaneously vaccinated with the first dose of ZOSTAVAX vaccine (Merck) (lot #663893/0128Y) into the right deltoid in a pharmacy on 11-MAR2009. Her family history included father (deceased) diabetes mellitus type 2 and hypertension, mother (alive) with hepatitis, unclear etiology, hypertension, and chronic pain, and one brother with diabetes mellitus type 2. Concomitant therapy also, included vitamin D (unspecified), METROGEL, COMBIVENT, omega-3 marine triglycerides, melatonin (+) pyridoxine, "ZICAM", nystatin (+) triamcinolone acetonide topical, aspirin, green tea extract, vitamins (unspecified), ALLEGRA, FLONASE along with lisinopril (manufacturer unknown) and NIASPAN. On 19-MAR-2009, 8 days after getting ZOSTAVAX vaccine (Merck) (previously reported as 9 days after vaccination), the patient had rash consistent with zoster injection breakout on her left chest and back. She was not ill when she got the vaccination and her lesions were better but still there. She was feeling better at time of reporting. The patient declined further testing. Additional information is not expected.
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood pressure increased
Clinical narrative: Information has been received from a consumer concerning her 76 year old husband who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). "About 1 week after vaccination", the patient experienced a rise in blood pressure. The patient  had not seen his doctor. His blood pressure was as high as 180/95. The outcome was unknown. The consumer also reported herself experienced a rise in blood pressure after vaccinated with ZOSTAVAX (Merck) (WAES # 0903USA04920). Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Information has been received from a licensed practical nurse concerning a male with no medical history or drug allergy who on 15-JAN-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot number not available). In January 2009, the patient developed shingles rash on the right side of his upper torso. It was noted that the patient did not have any pain associated with the rash. He did not perform lab diagnostics tests. Subsequently, the patient recovered on an unspecified date. The patient was seen at the practice for medical attention. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 70 year old female who on 12-MAR-2008 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 659759/1873U). On 09-MAR-2009 the patient developed shingles. At the time of this report, the outcome was unknown. Unspecified medical attention was sought. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site swelling, Mobility decreased, Myalgia
Clinical narrative: Information has been received from a female patient with no drug allergies/reactions and arthritis who on 18-MAR-2009 was vaccinated with ZOSTAVAX (Merck). Concomitant therapy included ARMOUR, LIPITOR and alprazolam. After getting ZOSTAVAX (Merck) on 23-MAR-2009 the patient experienced muscle pain from the knees down on both legs. The patient reported that she had not had muscle pain on the leg up to this point. The patient had soreness inside the knees and on the sides of the knees. It was really bad on 21-MAR-2009. The patient found it difficult to get up from a sitting position. The patient "felt like" she was "crippled". Once she was on her feet, it was manageable. The symptoms had improved but she was still having muscle aches. The patient was seen by an orthopedic and she could not find a cause. The patient also experienced swelling at the injection site for about 2-3 days. At the time of reporting, the patient had not recovered from the adverse events. This is one of several reports from the same source. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Axillary pain, Injected limb mobility decreased, Injection site pain, Malaise, Myalgia
Clinical narrative: Information has been received from a registered pharmacist concerning a female patient who on 18-FEB-2009 was vaccinated with ZOSTAVAX (Merck) subcutaneously. Concomitant therapy included " a statin". The patient had soreness at the injection site after ZOSTAVAX (Merck) was given. The registered pharmacist stated the patient then reported having "blotchy skin and not feeling well". The registered pharmacist further reported the patient's arm was still sore and she did not have full mobility of her arm. The registered pharmacist also stated there was "muscle pain in her arm as well as her arm pit". The patient had visited the registered pharmacist for medical attention. At the time of reporting the patient had not recovered from the adverse events. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Rash macular
Clinical narrative: Information has been received from a registered pharmacist concerning a female patient who on 18-FEB-2009 was vaccinated with ZOSTAVAX (Merck) subcutaneously. Concomitant therapy included " a statin". The patient had soreness at the injection site after ZOSTAVAX (Merck) was given. The registered pharmacist stated the patient then reported having "blotchy skin and not feeling well". The registered pharmacist further reported the patient's arm was still sore and she did not have full mobility of her arm. The registered pharmacist also stated there was "muscle pain in her arm as well as her arm pit". The patient had visited the registered pharmacist for medical attention. At the time of reporting the patient had not recovered from the adverse events. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Rash erythematous, Vaccination failure
Clinical narrative: Information has been received from a patient via of a letter who was vaccinated with a dose of ZOSTAVAX (Merck) on an unspecified date.  On 15-FEB-2009 the patient had awakened in the night with pain in the left outer thigh.  It felt like as though the patient had bumped into something and the patient could not determine the reason.  The patient thought a bruise would be seen.  No.  On 16-FEB-2009 at the same time, same thing, same time frame, the patient was stilled puzzled as to the cause.  On 17-FEB-2009, the same thing repeated.  The patient noticed a red eruption on the left inner thigh.  On 18-FEB-2009 the patient visited the doctor who readily verified that it was shingles.  The patient reported that she took 5 pills (not further specified) a day for one week and continued to have off and on pain in her left outer thigh and leg as well as discomfort in the inner thigh region.  On 04-MAR-2009, inner thigh rash was nearly gone.  However, some remains even as of 19-MAR-2009.  The pain persisted periodically in the outer hip, thigh and leg.  The patient considered ZOSTAVAX (Merck) did not work.  The patient thought there was unnecessary pain which the patient still experienced.  Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse practitioner concerning a 62 year old female with morphine allergy and medical history of breast cancer who on 26-MAR-2009 was subcutaneously vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck). There was no concomitant medication. On 27-MAR-2009 the patient experienced warmth, redness, and itching at site of injection after administration of ZOSTAVAX (Merck). The patient's skin felt lumpy but did not have any blisters or hives presented. The patient was treated with BENADRYL and VALTREX. At the time of reporting, the patient did not recover. The patient had an office visit for medical attention. Follow up information was received from the nurse practitioner who reported the retired female patient was subcutaneously vaccinated with the first dose of ZOSTAVAX (Merck) (lot # 663894/0129Y) into the right deltoid on 26-MAR2009. There was no illness at time of vaccination. In the afternoon on 26-MAR-2009, the patient developed localized rash, red, raised, and itching about 3 cm in diameter. On 02-APR-2009, the patient recovered from the above events. Addition information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Information has been received from a female with a medical history of Shingles, high Cholesterol and high blood pressure who was vaccinated with a dose of ZOSTAVAX (Merck) in January 2009. It was reported the patient has shingles long time ago even before she received ZOSTAVAX (Merck). The patient began getting rashes between her hips and gluteus area again in February 2009 and March 2009. She continued to get shingles every month after she received ZOSTAVAX (Merck). She was even prescribed (VALTREX) which just alleviated the symptoms. The patient was not hospitalized. No further information provided. Addition information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a medical assistant concerning a patient who was vaccinated with ZOSTAVAX (Merck). The patient developed a mild case of shingles after receiving the vaccine. The patient had sought unspecified medical attention. On an unspecified date, the patient recovered from the mild case of shingles. No further information is available.
Sex: U
Vaccine: VARZOS
Symptoms: Muscle spasms
Clinical narrative: Information has been received from a pharmacist concerning a patient who was vaccinated with ZOSTAVAX (Merck). The patient experienced a muscle spasm in hands and fingers within 20 minutes of administration of the vaccine. The patient had sought unspecified medical attention. The outcome of the patient's muscle spasm in hands and fingers was not reported. No further information is available.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a Registered Pharmacist (R. Ph.) concerning a 60 year old female who on 09-MAR-2009 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot# 663178/1414X). On 16-MAR-2009 the patient developed a rash on her hand and neck 7 days after the vaccine. At the time of reporting the patient had not recovered. The patient's physician felt the rash looked like "poison ivy". Pharmacist would be interested in PCR analysis. The patient sought unspecified medical attention. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site mass, Injection site rash, Injection site swelling
Clinical narrative: Information has been received from a registered pharmacist concerning a 60 year old female with "being sensitive to things" but no allergy to gelatin or NEOSPORIN who on 30-MAR-2009 was vaccinated with a dose of ZOSTAVAX (Merck). Her concomitant medications and past drug history were unknown. On 01-APR-2009 the patient experienced redness the size of an orange, and a golf ball size of lump/also reported as swelling over injection site. It was unknown if any relevant laboratory testing was performed. The outcome was not reported. Follow up information was received from the registered pharmacist who reported the female patient had rash after receiving the ZOSTAVAX vaccine (Merck). The patient informed the pharmacist the rash was the size of and orange and inside the rash there was brighter area that was the size of a golf ball. The rash was in the pattern of a maple leaf. The reporter was not sure if the rash had blisters as she stated the patient would be coming in the afternoon on 02-APR-2009. Additional information has been requested
Sex: U
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a consumer concerning "friend of a friend" who was vaccinated with ZOSTAVAX (Merck) a long while ago. The patient developed a rash which had since gone away. The outcome of the patient's rash was not reported. This is one of several reports from the same source. Attempts to verify the existence of an identifiable patient have been unsuccessful.
Sex: U
Vaccine: VARZOS
Symptoms: Myalgia
Clinical narrative: Information has been received from a consumer concerning "friend of a friend" who was vaccinated with ZOSTAVAX (Merck). On an unknown date the patient developed muscle pain at an unspecified area. The outcome of the patient's muscle pain at an unspecified area was not reported. This is one of several reports from the same source. Attempts to identify the existence of an identifiable patient were unsuccessful.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a registered pharmacist concerning a female who on approximately 12-MAR-2009 was vaccinated with a 0.65 mL dose of ZOSTAVAX (Merck), subcutaneously (lot #663881/1787X). The patient developed redness and swelling at the injection site. The patient sought medical attention through a pharmacist. The patient had not recovered. This is one of two reports from the same source. Additional information has been requested.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash pruritic, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 55 year old male patient with abnormal aneurysm, hypothyroidism, undefined anemia and scleroderma who about 3 months ago, in approximately January 2009, was vaccinated with ZOSAVAX (Merck). About 6 to 7 weeks after vaccination (about 1 month ago) the patient developed a widespread itchy varicella like rash. On an unspecified date the patient was seen for an office visit. The physician stated that he was not interested in a DCR analysis. At the time of reporting that he was not interested in a DCR analysis. At the time of reporting the patient had not recovered. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from an advance registered nurse practitioner concerning a male patient who on 03-MAR-2009 was vaccinated SQ with a 0.65 mL dose of ZOSTAVAX (Merck). About 3 weeks later the patient got shingles that "was not very bad". The nurse was not sure if the patient had a prior history of shingles but she said she would indicate this in follow-up because she did not have available the patient's chart. The patient called the office seeking medical attention. At the time of reporting the patient had not recovered. Additional information has been requested.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Pain, Rash
Clinical narrative: Information has been received from a nurse concerning a "over 60 year old" male who was vaccinated with ZOSTAVAX (Merck). In 2008 the patient developed shingles after received the vaccine. The patient experienced "pain, blistered, and rashes on his left side T4 dermatome". Lot number was not available. No further information was provided. The patient sought medical attention, form his physician. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site rash
Clinical narrative: Information has been received from a 66 year old female with reaction to BENEDRYL and reaction to cisplatin (+) doxorubicin (+) etoposide (+) vincristine sulfate and no pertinent medical history reported who on 31-MAR-2009 was vaccinated with ZOSTAVAX (Merck), 0.65 mL. Concomitant therapy included CLARINEX, RHINOCORT, "TRAVASTAND" and baby aspirin. The next day to the vaccine, on 01-APR-2009, the patient experienced a rash of 3 inches by 4 inches in the arm where ZOSTAVAX (Merck) was given. The rash was red with little bumps and sore to touch. The patient sought unspecified medical attention. No labs were done. At the time of reporting the patient had not recovered. Additional information has been requested.
Age: 38.0
Sex: M
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a medical assistant concerning a 38 year old male patient who was inadvertently vaccinated with ZOSTAVAX (Merck) instead of VARIVAX due to nursing error. No adverse effect reported. Follow-up information was received from the medical assistant and physician via telephone call providing patient's name and date of birth. She also provided the vaccine lot number: ZOSTAVAX (Merck) (Lot # 663673/1710X). The physician stated that the ZOSTAVAX (Merck) and VARIVAX were both kept in the freezer. She said that "the nurse thought it was the same vaccine" and that the nurse did not know they were 2 different vaccines. No further information is available.
Age: 90.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: Information has been received from a 90 year old female consumer with no pertinent medical history and no known drug allergies, who on 17-MAR-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (lot not reported). There was no concomitant medication. On 01-APR-2009 the patient developed shingles and had pain on the left side beneath her left breast around the back. The patient sought unspecified medical attention. At the time of reporting, 02-APR-2009, the outcome eof the patient was unknown. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a Medical Assistant concerning a female patient who on 02-APR-2009 was accidentally vaccinated with ZOSTAVAX (Merck) (Lot# not reported) instead Varicella. No adverse effect was reported. Additional information has been requested.
Age: 78.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 78 year old male patient who in January 2008, was vaccinated with a dose of 0.65 ml ZOSTAVAX (Merck) (Lot number not provided). A little more than a year after receiving ZOSTAVAX (Merck), in March 2009, the patient was diagnosed with shingles. The physician stated that "It had improved however the patient was still recovering". The patient sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: Information has been received from a female patient with no known drug reactions/allergies and no pertinent medical history, who on 18 18-DEC-2008 was vaccinated with ZOSTAVAX (Merck), 0.65ml. No lot number was provided. There was no concomitant medication. The patient reported that on approximately 01-JAN-2009, two weeks after vaccination, she developed a case of shingles. At the reporting time, she was experiencing a little pain however the most of the pain had went away. The patient stated that she had a feeling she may had had the shingles before receiving the vaccine however she was not diagnosed with them. Patient did not want to provide physician's name. At the time of the report, the patient was recovering. The patient sought unspecified medical attention. Additional information is not expected.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Influenza like illness, Injection site erythema, Injection site induration
Clinical narrative: Information has been received from a 73 year old female nurse practitioner with penicillin, codeine and MOTRIN allergies who on 27-MAR-2009 were vaccinated with a dose of ZOSTAVAX (Merck), subcutaneously. There was no concomitant medication. On 01-APR-2009 the patient experienced swelling, redness, and hardness at the injection site; she also experienced headache, fatigue and general flu like symptoms. No laboratories studies performed. The patient sought medical attention at the clinic. The patient had not recovered. Additional information has been requested.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a 73 year old female nurse practitioner with penicillin, codeine and MOTRIN allergies who on 27-MAR-2009 were vaccinated with a dose of ZOSTAVAX (Merck), subcutaneously. There was no concomitant medication. On 01-APR-2009 the patient experienced swelling, redness, and hardness at the injection site; she also experienced headache, fatigue and general flu like symptoms. No laboratories studies performed. The patient sought medical attention at the clinic. The patient had not recovered. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Information has been received from a female patient who was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# not provided). Subsequently the patient experienced redness at the injection site. No further information is available.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site erythema, Injection site pain, Injection site reaction, Injection site streaking
Clinical narrative: Information has been received from an 81 year old female patient with no pertinent medical history and no known drug allergies, who on approximately 31-MAR-2009 ("last Tuesday") was vaccinated with a dose of ZOSTAVAX (Merck) (lot # not provided). Concomitant therapy included (REQUIP), (LYRICA) and (PROTONIX). Subsequently the patient experienced injection site reaction and a little bit of a headache. Her injection site is a little sore and there is a red streak under the skin running from the injection site to the elbow. No lab diagnostic studies were performed. At the time of the report the patient had not yet recovered. No further information is available.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache
Clinical narrative: Information has been received from a 67 year old female with no pertinent medical history and no known drug allergies, who on 30-MAR-2009 was vaccinated with a 0.65mL dose of ZOSTAVAX (Merck) (route and lot number not provided). Concomitant medication included "medication for hot flashes and thyroid medications". Three days after vaccination, on 02-APR-2009, the patient experienced headache. When she woke up on 03-APR-2009, the headache was gone. No lab studies were performed. The patient sought unspecified medical attention. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site mass, Injection site swelling, Injection site warmth, Pain
Clinical narrative: Information has been received from a medical assistant concerning a 51 year old female patient with osteoporosis and sulfonamide allergy, who on 01-APR-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # 663881/0197Y). Concomitant therapy included (BONIVA), cephalexin, lovastatin and (VICODIN). On 02-APR-2009, the patient notice "a lump, redness, swelling and warmth at the injection site where ZOSTAVAX (Merck) was given". On 03-APR-2009, the patient had a slight fever, soreness and mild body aches. The area was still warm to touch. The patient had an office visit. At the time of reporting, the patient had not recovered. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Information has been received from a medical assistant concerning a 51 year old female patient with osteoporosis and sulfonamide allergy, who on 01-APR-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # 663881/0197Y). Concomitant therapy included (BONIVA), cephalexin, lovastatin and (VICODIN). On 02-APR-2009, the patient notice "a lump, redness, swelling and warmth at the injection site where ZOSTAVAX (Merck) was given". On 03-APR-2009, the patient had a slight fever, soreness and mild body aches. The area was still warm to touch. The patient had an office visit. At the time of reporting, the patient had not recovered. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Contusion, Pruritus, Swelling
Clinical narrative: Information has been received from a Registered Pharmacist concerning a "over age of 65" female who on approximately 27-MAR-2009, " about 1 week ago" was vaccinated with ZOSTAVAX (Merck) (lot # not reported), 0.65 ml via subcutaneous. On approximately 28-MAR-2009, the day after receiving ZOSTAVAX (Merck), the patient experienced itching, swelling and bruising. The patient's itching and swelling and bruising persisted. On an unspecified date, the patient sought medical attention, via pharmacist. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a physician concerning a female in her 60's who was vaccinated with a dose of ZOSTAVAX (Merck) (Lot number not known). Subsequently the patient developed a " zoster like rash" on the palm of  her hand up to her arm. The patient sought medical attention by visiting the physician's office. At the time of reporting the patient was not recovered. Additional information has been requested.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Dizziness, Dysgeusia, Incorrect route of drug administration
Clinical narrative: Information has been received from a Certified Medical Assistant (C.M.A) concerning a 64 year old male with gastroesophageal reflux disease and no drug allergies who on 06-APR-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (lot# 664091/0140Y) intramuscularly instead of subcutaneously. Concomitant therapy included PROTONIX, Fish oil, Calcium and Vitamins. It was reported that the patient was lightheaded and experienced a bad taste in his mouth. The patient was recovering. The patient did not seek medical attention. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Chest pain, Electrocardiogram normal
Clinical narrative: Information has been received from a Nurse Practitioner (N.P.) concerning a 70 year old female who in February 2009 was vaccinated with a dose of ZOSTAVAX (Merck).  The patient experienced chest pain 3 days later.  The patient sought medical attention and was seen by nurse practitioner.  Electrocardiogram test indicated normal.  Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site warmth, Pyrexia
Clinical narrative: Information has been received from a Nurse Practitioner (N.P.) concerning a 62 year old female who on 03-APR-2009 was vaccinated subcutaneously with a dose of ZOSTAVAX (Merck). The patient had "redness, warmth, and induration at the injection site after the vaccine". It was reported the patient "also had a low grade fever of 99.0 F and was started an antibiotic". The patient sought medical attention and was seen by nurse practitioner. The patient was recovering. Additional information has been requested.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Axillary pain, Breast mass, Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: Information has been received from a physician assistant concerning a female patient with fibrocystic breast and without drug allergy who was subcutaneously vaccinated with a dose of ZOSTAVAX (Merck) on 02-Mar-2009. Subsequently, the patient called in the afternoon on 02-Mar-2009 stating that she experienced swelling, redness and a 2inch lump at the injection site. The patient went to the office on 06-Apr-2009 complaining of pain under armpit on her left side that comes and goes with certain movements. The reporter was not sure if that was vaccine related. The patient sought unspecified medical attention. Follow up information was received from the physician's assistant and registered nurse concerning a 72 year old (also reported) as 73 year old) female who at 10:00 on 02-Mar-2009 was subcutaneously vaccinated with the first dose of ZOSTAVAX (Merck) (lot# 663895/0135Y) into the left arm. On 04-Mar-2009 the patient reported she developed redness, pain, and swelling at the injection site at left arm on 03-Mar-2009 (previously reported as 02-Mar-2009). The swelling consisted of a 2 inch diameter lump. On 06-Mar-2009, left breast ultrasound showed abnormal lymph nodes in left axilla. Swelling at the injection site had received at the time but redness persisted. On 07-Mar-2009, swelling at the injection site had resolved at that time but redness persisted. On 07-Mar-2009, swelling in left axilla resolved which took 5-6 days. On 06-Apr-2009 the patient still reported pain in the left axilla with certain movement of left arm. The patient recovered on 12-Apr-2009. The result of mammogram and ultrasound on 06-Mar-2009 was compared with the ultrasound result of 15-Aug-2007, which had showed a small hypoechoic nodule at the 2 o'clock A position the findings of the ultrasound on 06-Mar-2009 included: no suspicious mass or cyst was seen in patient's area of palpated abnormally. A ridge of prominent parenchyma tissue was seen at the 10 o'clock B position in area of palpated lump. A small hypoechoic nodule at the 2 o' clock A position was again demonstrated, decreased in size versus previous study . This nodule now measured 3.7 mm in diameter and had no internal flow. Of note, there were two abnormal appearing lymph nodes in the left axilla, each of which measured approximately 1cm in diameter. Both of these lymph nodes were round, hypoechoic and lack discrete fatty hilum. Impression included: Benign findings in the left breast. A hypoechoic nodule in the 2 o 'clock A position has decreased in size in the interim,  likely representing an involving cyst or small area of fibrocystic charge. There was no ultrasound abnormally at area of palpated lump at the 10 o' clock position. Two abnormal lymph nodes in the left axilla were likely reactive. Of note, patient received ZOSTAVAX (Merck) in the left axilla were likely reactive. Of note, patient would follow up with her clinician for further evaluation of these likely reactive nodes. Additional information is not expected.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling, Lymphadenopathy, Mammogram abnormal, Ultrasound scan abnormal
Clinical narrative: Information has been received from a physician assistant concerning a female patient with fibrocystic breast and without drug allergy who was subcutaneously vaccinated with a dose of ZOSTAVAX (Merck) on 02-Mar-2009. Subsequently, the patient called in the afternoon on 02-Mar-2009 stating that she experienced swelling, redness and a 2inch lump at the injection site. The patient went to the office on 06-Apr-2009 complaining of pain under armpit on her left side that comes and goes with certain movements. The reporter was not sure if that was vaccine related. The patient sought unspecified medical attention. Follow up information was received from the physician's assistant and registered nurse concerning a 72 year old (also reported) as 73 year old) female who at 10:00 on 02-Mar-2009 was subcutaneously vaccinated with the first dose of ZOSTAVAX (Merck) (lot# 663895/0135Y) into the left arm. On 04-Mar-2009 the patient reported she developed redness, pain, and swelling at the injection site at left arm on 03-Mar-2009 (previously reported as 02-Mar-2009). The swelling consisted of a 2 inch diameter lump. On 06-Mar-2009, left breast ultrasound showed abnormal lymph nodes in left axilla. Swelling at the injection site had received at the time but redness persisted. On 07-Mar-2009, swelling at the injection site had resolved at that time but redness persisted. On 07-Mar-2009, swelling in left axilla resolved which took 5-6 days. On 06-Apr-2009 the patient still reported pain in the left axilla with certain movement of left arm. The patient recovered on 12-Apr-2009. The result of mammogram and ultrasound on 06-Mar-2009 was compared with the ultrasound result of 15-Aug-2007, which had showed a small hypoechoic nodule at the 2 o'clock A position the findings of the ultrasound on 06-Mar-2009 included: no suspicious mass or cyst was seen in patient's area of palpated abnormally. A ridge of prominent parenchyma tissue was seen at the 10 o'clock B position in area of palpated lump. A small hypoechoic nodule at the 2 o' clock A position was again demonstrated, decreased in size versus previous study . This nodule now measured 3.7 mm in diameter and had no internal flow. Of note, there were two abnormal appearing lymph nodes in the left axilla, each of which measured approximately 1cm in diameter. Both of these lymph nodes were round, hypoechoic and lack discrete fatty hilum. Impression included: Benign findings in the left breast. A hypoechoic nodule in the 2 o 'clock A position has decreased in size in the interim,  likely representing an involving cyst or small area of fibrocystic charge. There was no ultrasound abnormally at area of palpated lump at the 10 o' clock position. Two abnormal lymph nodes in the left axilla were likely reactive. Of note, patient received ZOSTAVAX (Merck) in the left axilla were likely reactive. Of note, patient would follow up with her clinician for further evaluation of these likely reactive nodes. Additional information is not expected.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Information has been received from a physician with allergy to penicillin who on 06-APR-2009 was administered ZOSTAVAX (Merck) (lot # not available) intramuscularly by a pharmacist. The physician stated that it was sore at the time of injection. The outcome of the patient's adverse event was not reported. Additional information has been expected.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Culture, Herpes zoster, Pain, Rash
Clinical narrative: Information has been received from a pharmacist concerning a 65 year old female with blood pressure high who on 20-MAR-2009 was vaccinated with ZOSTAVAX vaccine (Merck). Concomitant therapy included lisinopril (manufacturer unknown). About 5 days after vaccination, on 26-MAR-2009 the patient developed shingles. The patient came to the phone and provided more information. The patient's most intense pain was on her right side back and front of her body. The rash was on the right side waist area and right side center back. The patient was prescribed acyclovir for 7 days and was still taking VICODIN for pain. Her physician had "cultured" the rash. The rash was at time of reporting improved, but her whole body was still in pain. The patient was seen in office for medical attention. At the time of reporting the patient was recovering from adverse events. Follow-up information has been received that on 20-MAR-2009 13:20 the patient was vaccinated with her second dose of ZOSTAVAX vaccine (Merck) (lot # 663671/1708X) into her left arm. On 26-MAR-2009 the patient's rash was consistent with zoster. The culture was taken but with no growth. Clinical picture showed pain consistent with zoster. The patient was treated with antiviral medication and "pain."  Follow up information was received from a Medical Assistant of the physician by phone on 05-MAY-2009 reported that the patient's age was 65 year old (not 45 years of age as previous reported). The description of the adverse event should read, "rash consistent with zoster, culture taken but no growth, clinical picture with pain consistent with zoster, treated with antivirals and and pain medicines". Event was not an other important medical event (event required medical intervention but the intervention was not to prevent a serious outcome); pain was not measured on the pain scale; patient was prescribed with VICODIN, as required, for pain relief; antivirals included acyclovir, 800 mg, five times daily for 7 days and VALTREX, 1 gram, three times daily; chart did not show if patient had history of chickenpox or any recent exposure to chickenpox; as of 28-APR-2009, the patient was still recovering from event. No further information is available.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash macular
Clinical narrative: Information has been received from a registered pharmacist concerning a 67 year old female patient with hypertension, hypercholesterolemia and no drug allergy who was subcutaneously vaccinated with a dose of ZOSTAVAX (Merck) in the arm on 02-APR-2009. Concomitant therapy included LIPITOR and  lisinopril (manufacturer unknown). At night on 06-APR-2009, the patient developed one blotchy spot that was the shape of a spread out wing right above the chest. The spot resolved by the noon of the next day (07-APR-2009). Lab test was not performed. The patient spoke to unspecified health professional at the same practice for medical attention. Additional information has been requested.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Ear pain, Pain of skin, Skin lesion
Clinical narrative: Information has been received from a physician concerning a 64 year old male consumer who got the ZOSTERVAX (Merck), unknown dose and frequency, on 03-APR-2009, for an unknown indication. The patient's relevant medical history and relevant past drug history include melanoma treated with chemotherapy over a year ago. The patient relevant concomitant medication are unknown. This physician reports that 2 days after he got the ZOSTAVAX (Merck), on 05-APR-2009, he developed pain in his scalp and left ear. She reports that today, on 08-APR-2009, he has linear lesions along the nerve line and at the angle of his eye, which she reports to be a medical emergency. As of 08-APR-2009, it is unknown if he will continue to get ZOSTAVAX (Merck), it is unknown if he continues to have pain in his scalp and left car, and he continues to have linear lesions along the nerve line and at the angle of his eye.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Endoscopy, Herpes zoster
Clinical narrative: Information has been received from a 59 year old female with a history of perforated ulcer and no known drug allergies, who on 18-FEB-2009 was vaccinated with 0.65 ml dose ZOSTAVAX (Merck) (lot not reported) subcutaneously. Concomitant therapy included lovastatin, enalapril maleate, aminopyrine, alendronate sodium and omeprazole. On 21-MA@-2009 (reported as within three days of getting vaccinated), the patient developed shingles and " gastric problems". On an unspecified date the patient underwent and endoscopy (results not reported). The patient sought unspecified medical attention. At the time of reporting, 09-APR-2009, the patient was recovering. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: Information has been received from medical assistant concerning a female patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). It was reported that the patient developed widespread pruritus "about three weeks" after receiving ZOSTAVAX (Merck). It was reported that the patient contacted the office by phone. There was no laboratory diagnostic tests performed. It was reported that the patient had not recovered at the time of the report. Additional information has been requested.